References
- Dimaras H, Corson TW, Cobrinik D, White A, Zhao J, Munier FL, et al. Retinoblastoma. Nat Rev Dis Primers 2015;1:15021.
- Satyanarayana L, Asthana S, Labani S P. Childhood cancer incidence in India: A review of population-based cancer registries. Indian Pediatr 2014;51:218-20.
- Rao R, Honavar SG. Retinoblastoma. Indian J Pediatr 2017;84:937-44.
- Dimaras H, Kimani K, Dimba EA, Gronsdahl P, White A, Chan HS, et al. Retinoblastoma. Lancet 2012;379:1436-46.
- Chen M, Jiang H, Zhang J, Shen G, Jiang Y, Li H, et al. Outcome of intra-arterial chemotherapy for retinoblastoma and its influencing factors: A retrospective study. Acta Ophthalmol 2017;95:613-8.
- Murphree AL. Intraocular retinoblastoma: The case for a new group classification. Ophthalmol Clin North Am 2005;18:41-53.
- UKCCSG Retinoblastoma Working Group. Guidelines for the Management of Children with Advanced Retinoblastoma Following Primary Enucleation, Version 1.0; 2005.
- Manjandavida FP, Shields CL. The role of intravitreal chemotherapy for retinoblastoma. Indian J Ophthalmol 2015;63:141-5.
- Chantada GL, Fandino AC, Carcaboso AM, Lagomarsino E, de Davila MT, Guitter MR, et al. A phase I study of periocular topotecan in children with intraocular retinoblastoma. Invest Ophthalmol Vis Sci 2009;50:1492-6.
- Mruthyunjaya P, Kingston JE, Hungerford JL. Treatment outcomes and globe salvage using second line chemotherapy in advanced retinoblastoma. Invest Ophthalmol Vis Sci 2006;47:2291.
- Abramson DH. Chemosurgery for retinoblastoma: What we know after 5 years. Arch Ophthalmol 2011;129:1492-4.
- Manjandavida FP, Stathopoulos C, Zhang J, Honavar SG, Shields CL. Intra-arterial chemotherapy in retinoblastoma a paradigm change. Indian J Ophthalmol 2019;67:740-54.
- Gao J, Zeng J, Guo B, He W, Chen J, Lu F, et al. Clinical presentation and treatment outcome of retinoblastoma in children of South Western China. Medicine (Baltimore) 2016;95:e5204.
- Waddell KM, Kagame K, Ndamira A, Twinamasiko A, Picton SV, Simmons IG, et al. Clinical features and survival among children with retinoblastoma in Uganda. Br J Ophthalmol 2015;99:387-90.
- Sthapit PR, Rao R, Honavar SG. Periocular topotecan for vitreous seeds in retinoblastoma. Indian J Ophthalmol 2018;66:1833-8.
- Marr BP, Dunkel IJ, Linker A, Abramson DH. Periocular carboplatin for retinoblastoma: Long-term report (12 years) on efficacy and toxicity. Br J Ophthalmol 2012;96:881-3.